Korea S.E.
06:00:00 2024-05-23 pm EDT
5-day change
1st Jan Change
3,500
KRW
+9.89%
+33.59%
+6.87%
Apr. 26
ADBiotech Co., Ltd. announced that it has received KRW 4.5 billion in funding from Kiwoom Securities Co., Ltd., NH Investment & Securities Co., Ltd., Samsung Securities Co.,Ltd., Mirae Asset Securities Co., Ltd., KB Securities Co.,Ltd
CI
Apr. 25
ADBiotech Co., Ltd. announced that it expects to receive KRW 4.5 billion in funding from Kiwoom Securities Co., Ltd., NH Investment & Securities Co., Ltd., Samsung Securities Co.,Ltd., Mirae Asset Securities Co., Ltd., KB Securities Co.,Ltd
CI
ADBiotech Co., Ltd. announced that it has received KRW 4.5 billion in funding
On May 3, 2021, ADBiotech Co., Ltd. (XKON:A179530) closed the transaction.
ADBiotech Co., Ltd. announced that it has received KRW 4.5 billion in funding from Kiwoom Securities Co., Ltd., NH Investment & Securities Co., Ltd., Samsung Securities Co.,Ltd., Mirae Asset Securities Co., Ltd., KB Securities Co.,Ltd
Apr. 25
CI
ADBiotech Co., Ltd. announced that it expects to receive KRW 4.5 billion in funding from Kiwoom Securities Co., Ltd., NH Investment & Securities Co., Ltd., Samsung Securities Co.,Ltd., Mirae Asset Securities Co., Ltd., KB Securities Co.,Ltd
Apr. 24
CI
ADBiotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
23-03-22
CI
ADBiotech Co., Ltd. agreed to acquire a 19.36% stake in Wiju Inc. for KRW 1.29 billion.
23-01-15
CI
ADBiotech Co., Ltd. announced that it has received KRW 4.5 billion in funding
21-05-02
CI
ADBiotech Co., Ltd. announced that it expects to receive KRW 4.5 billion in funding
21-04-21
CI
ADBiotech Co., Ltd. announced that it has received KRW 3.0000065 billion in funding from SBI Investment Korea Co., Ltd.
20-07-08
CI
ADBiotech Co., Ltd. announced that it has received KRW 1 billion in funding
20-07-08
CI
ADBiotech Co., Ltd. announced that it expects to receive KRW 1 billion in funding
20-06-29
CI
ADBiotech Co., Ltd. announced that it expects to receive KRW 3.0000065 billion in funding from SBI Investment Korea Co., Ltd.
20-06-28
CI
Quest PharmaTech, Inc. announced that it has received CAD 1 million in funding from AD Biotech. Co., Ltd and another investor.
14-01-28
CI
Quest PharmaTech, Inc. announced that it expects to receive CAD 1 million in funding.
13-11-20
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
ADBiotech Co Ltd is a Korea-based company mainly engaged in the manufacture and sale of veterinary drugs. The Company operates its business through two segments. Veterinary Medicine segment is engaged in the manufacture and sale of antibiotics, anticoccidial agents, antimicrobial agents, nervous system agents, synthetic antibacterial agents and others. The Supplementary Feed segment is engaged in the manufacture and sale of functional supplementary feeds and other products.
More about the company
1st Jan change
Capi.
+6.87% 21.31M -13.83% 77.98B +24.00% 3.66B +0.14% 3.26B +14.70% 1.63B -4.46% 1.6B +2.54% 1.34B -22.01% 1.31B -12.12% 1.18B +1.55% 1.11B
Veterinary Drugs
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
ADBIOTECH CO., LTD. 
